Vanda Pharmaceuticals (VNDA) Prepaid Assets (2010 - 2026)
Vanda Pharmaceuticals' (VNDA) quarterly Prepaid Assets came in at $32.3 million in Q1 2026, up 57.65% year-on-year from $20.5 million in Q1 2025, and up 19.63% quarter-over-quarter from $27.0 million in Q4 2025.
Vanda Pharmaceuticals (VNDA) Prepaid Assets (2010 - 2026) Analysis & Trends
Vanda Pharmaceuticals has disclosed Prepaid Assets across 17 years of filings, most recently posting $32.3 million for Q1 2026.
- Prepaid Assets for Q1 2026 came in at $32.3 million, up 57.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $32.3 million (up 57.65% YoY), and the FY2025 annual result was $27.0 million, up 75.0% from the prior year.
- Prepaid Assets came in at $32.3 million for Q1 2026 at Vanda Pharmaceuticals, up from $27.0 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $32.3 million in Q1 2026 to a low of $6.6 million in Q1 2023.
- The 5-year median for Prepaid Assets is $17.7 million (2022), against an average of $17.5 million.
- Across the five-year window, Prepaid Assets sank 73.95% in 2023 and surged 189.82% in 2025, its largest moves.
- Vanda Pharmaceuticals' Prepaid Assets stood at $17.7 million in 2022, then slumped by 48.27% to $9.2 million in 2023, then jumped by 68.16% to $15.4 million in 2024, then surged by 75.0% to $27.0 million in 2025, then climbed by 19.63% to $32.3 million in 2026.
- The last three Prepaid Assets figures came in at $32.3 million (Q1 2026), $27.0 million (Q4 2025), and $21.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Vanda Pharmaceuticals | 345.46 Mn | 143.15 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.28 Mn |
| Dec 31, 2025 | 26.99 Mn |
| Sep 30, 2025 | 21.16 Mn |
| Jun 30, 2025 | 22.21 Mn |
| Mar 31, 2025 | 20.48 Mn |
| Dec 31, 2024 | 15.42 Mn |
| Sep 30, 2024 | 11.76 Mn |
| Jun 30, 2024 | 8.17 Mn |
| Mar 31, 2024 | 7.07 Mn |
| Dec 31, 2023 | 9.17 Mn |
| Sep 30, 2023 | 16.44 Mn |
| Jun 30, 2023 | 9.45 Mn |
| Mar 31, 2023 | 6.59 Mn |
| Dec 31, 2022 | 17.73 Mn |
| Sep 30, 2022 | 21.37 Mn |
| Jun 30, 2022 | 25.74 Mn |
| Mar 31, 2022 | 25.31 Mn |
| Dec 31, 2021 | 12.00 Mn |
| Sep 30, 2021 | 13.44 Mn |
| Jun 30, 2021 | 12.01 Mn |